Sage Journals: Discover world-class research

Abstract

The first class 1 treatment trial ever conducted in multiple sclerosis (MS) was a Veterans Administration Cooperative Study. This led us to explore MS in the military–veteran populations of the United States in three main series: Army men hospitalized with final diagnoses of MS in World War II, all veterans of World War II and the Korean Conflict, and veterans of later service up to 1994. In each series, all cases had been matched with pre-illness military peers. These series provide major information on its clinical features, course and prognosis, including survival, by sex and race (white men and women; black men), as well as risk factors for occurrence, course, and survival. They comprise the only available nationwide morbidity distributions of MS in the United States. Veterans who are service-connected for MS by the Department of Veterans Affairs and matched with their military peers remain a unique and currently available resource for further clinical and epidemiological study of this disease.

Keywords

clinical features course geographic distribution multiple sclerosis prognosis risk factors survival veterans

Get full access to this article

View all access options for this article.

References

1 Veterans Administration Multiple Sclerosis Study Group [Nagler, B, chairman]. Isoniazid in treatment of multiple sclerosis. Report of Veterans Administration cooperative study. JAMA 1957; 163: 168–172.

2 Kurtzke JF Berlin L . The effects of isoniazid on patients with multiple sclerosis. Preliminary report. Am Rev Tuberc 1954; 70: 577–592.

3 Kurtzke JF Berlin L . Isoniazid in treatment of multiple sclerosis. JAMA 1957; 163: 172–174.

4 Kurtzke JF . A new scale for evaluating disability in multiple sclerosis. Neurology 1955; 5: 580–583.

5 Kurtzke JF . On the evaluation of disability in multiple sclerosis. Neurology 1961; 11: 686–694.

6 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.

7 Kurtzke JF . Historical and clinical perspectives of the Expanded Disability Status Scale. Neuroepidemiology 2008; 31: 1–9 http://www.karger.com./ned (accessed 6 June 2008) 10.1159/000136645.

8 Nagler B Beebe GW Kurtzke JF Kurland LT Auth TL Nefzger MD . Studies on the natural history of multiple sclerosis. 1. Design and diagnosis. Acta Neurol Scand 1966; 42(Suppl. 19): 141–156.

9 Schumacher GA Beebe G Kibler RF . Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci 1965; 122: 552–568.

10.

10 Kurtzke JF Beebe GW Nagler B Auth TL Kurland LT . Studies on the natural history of multiple sclerosis. 6. Clinical and laboratory findings at first diagnosis. Acta Neurol Scand 1972; 48: 19–46.

11.

11 Beebe GW Kurtzke JF Kurland LT Auth TL Nagler B . Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the Army experience in World War II. Neurology 1967; 17: 1–17.

12.

12 Kurtzke JF . Neurologic impairment in multiple sclerosis and the disability status scale. Acta Neurol Scand 1970; 46: 493–512.

13.

13 Kurtzke JF . Risk factors, course, and prognosis of multiple sclerosis. In: CL Cazzullo D Caputo A Ghezzi M Zaffaroni , (eds), Virology and immunology of multiple sclerosis. Rationale for therapy. Berlin, Springer-Verlag; 1986. p. 349–357.

14.

14 Kurtzke JF Beebe GW Nagler B Kurland LT Auth TL . Studies on the natural history of multiple sclerosis: 8. early prognostic features of the later course of the illness. J Chronic Dis 1977; 30: 819–830.

15.

15 Kurtzke JF Beebe GW Norman JE . Epidemiology of multiple sclerosis in United States veterans: 1. Race, sex, and geographic distribution. Neurology 1979; 29: 1228–1235.

16.

16 Kurtzke JF Page WF . Epidemiology of multiple sclerosis in US veterans VII. Risk factors for MS. Neurology 1997; 48: 204–213.

17.

17 Wallin MT Page WF Kurtzke JF . Epidemiology of multiple sclerosis in US veterans: VIII. Long-term survival after onset of multiple sclerosis. Brain 2000; 123: 1677–1682.

18.

18 Wallin MT Page WF Kurtzke JF . Multiple sclerosis in United States veterans of Vietnam era and later military service. 1: race, sex and geography. Ann Neurol 2004; 55: 65–71.

19.

19 Wallin MT Kurtzke JF . Neuroepidemiology. In: Bradley, WG, Daroff, RB, Fenichel, GM, Jankovic, J, (eds), Neurology in clinical practice, vol. 1, 5th ed. Philadelphia, Butterworth, Heinemann, Elsevier; 2008. p. 763–780.

20.

20 Kurtzke JF Lux WE . In defense of death data: an example with multiple sclerosis. Neurology 1985; 35: 1787–1790.

Some contributions of the Department of Veterans Affairs to the epidemiology of multiple sclerosis

Abstract

Keywords

Get full access to this article

References